Your browser doesn't support javascript.
loading
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Tomasevic, Zorica; Denduluri, Neelima; Separovic, Robert; Gokmen, Erhan; Bashford, Anna; Ruiz Borrego, Manuel; Kim, Sung-Bae; Jakobsen, Erik Hugger; Ciceniene, Audrone; Inoue, Kenichi; Overkamp, Friedrich; Heijns, Joan B; Armstrong, Anne C; Link, John S; Joy, Anil Abraham; Bryce, Richard; Wong, Alvin; Moran, Susan; Yao, Bin; Xu, Feng; Auerbach, Alan; Buyse, Marc; Chan, Arlene.
Afiliación
  • Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain. Electronic address: mmartin@geicam.org.
  • Holmes FA; Texas Oncology, Houston, TX, USA.
  • Ejlertsen B; Rigshospitalet, Copenhagen, Denmark.
  • Delaloge S; Institut Gustave Roussy, Villejuif, France.
  • Moy B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Iwata H; Aichi Cancer Center, Chikusa-ku, Nagoya, Japan.
  • von Minckwitz G; Luisenkrankenhaus, German Breast Group Forschungs GmbH, Düsseldorf, Neulsenburg, Germany.
  • Chia SKL; BC Cancer Agency, Vancouver, BC, Canada.
  • Mansi J; Guy's and St Thomas' Hospital National Health Service Foundation Trust and Biomedical Research Centre, King's College, London, UK.
  • Barrios CH; Pontifical Catholic University of Rio Grande do Sul School of Medicine, Porto Alegre, Brazil.
  • Gnant M; Department of Surgery and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
  • Tomasevic Z; Daily Chemotherapy Hospital, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Denduluri N; Virginia Cancer Specialists, Arlington, VA, USA.
  • Separovic R; University Hospital for Tumors, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia.
  • Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey.
  • Bashford A; Auckland Hospital, Auckland, New Zealand.
  • Ruiz Borrego M; Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jakobsen EH; Department of Oncology, Lillebaelt Hospital, Vejle, Denmark.
  • Ciceniene A; Oncology Institute of Vilnius University, Vilnius, Lithuania.
  • Inoue K; Breast Oncology, Saitama Cancer Center, Kita-Adachi, Japan.
  • Overkamp F; Oncologianova GmbH, Recklinghausen, Germany.
  • Heijns JB; Department of Medical Oncology, Amphia Hospital, Breda, Netherlands.
  • Armstrong AC; Department of Oncology, Christie Hospital Manchester, Manchester, UK.
  • Link JS; Breastlink Medical Group Inc, Santa Ana, CA, USA.
  • Joy AA; University of Alberta, Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada.
  • Bryce R; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Wong A; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Moran S; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Yao B; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Xu F; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Auerbach A; Puma Biotechnology Inc, Los Angeles, CA, USA.
  • Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium.
  • Chan A; Breast Cancer Research Centre-Western Australia, Perth, WA, Australia; Curtin University, Perth, WA, Australia.
Lancet Oncol ; 18(12): 1688-1700, 2017 12.
Article en En | MEDLINE | ID: mdl-29146401
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Trastuzumab Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article